P/117/2010
Key facts
| Active substance |
|
| Therapeutic area |
Immunology-Rheumatology-Transplantation
|
| Decision number |
P/117/2010
|
| PIP number |
P/117/2010
|
| Pharmaceutical form(s) |
Modified release capsule
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Temmler Werke GmbH
E-mail: avril.mankel@ndareg.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|